Park Square has placed Srikanth Pendyala, M.D. as Chief Medical Officer at Infinimmune.
| less than a minute read
Infinimmune Appoints Srikanth Pendyala, M.D., as Chief Medical Officer
Get in touch
Get in touch
Infinimmune, a biotechnology company pioneering antibody discovery and design, today announced the appointment of Srikanth Pendyala, M.D., as Chief Medical Officer. In this role, Dr. Pendyala will lead clinical and regulatory strategy across Infinimmune’s pipeline, including first-in-human trials of IFX-101 and IFX-201.
Get in touch
Get in touch
Latest Insights
